Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.770
+0.050 (1.06%)
At close: May 19, 2026, 4:00 PM EDT
4.448
-0.322 (-6.76%)
After-hours: May 19, 2026, 7:50 PM EDT

Neuphoria Therapeutics Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
19.4414.2112.6112.123.1521.37
Cash & Short-Term Investments
19.4414.2112.6112.123.1521.37
Cash Growth
14.06%12.71%4.17%-47.72%8.34%576.52%
Other Receivables
1.610.010.130.43--
Total Trade Receivables
1.610.010.130.43--
Other Current Assets
0.610.820.460.8--
Total Current Assets
21.6615.0413.1913.3328.8423.19
Net Property, Plant & Equipment
-0.110.220.330.470.65
Other Intangible Assets
4.314.85.476.13--
Goodwill
8.848.648.698.698.889.3
Other Long-Term Assets
--0.080.08--
Total Assets
34.8128.5927.6528.5645.0540.69
Accounts Payable
0.631.152.241.44--
Accrued Expenses
0.892.951.461.19--
Current Portion of Leases
-0.120.120.110.110.13
Total Current Liabilities
1.514.223.832.742.311.77
Long-Term Leases
--0.120.240.370.52
Other Long-Term Liabilities
3.875.376.213.573.12.7
Total Long-Term Liabilities
3.875.376.333.813.473.22
Total Liabilities
5.399.5910.166.555.795
Common Stock
000-150.16142.61
Additional Paid-in Capital
218.39200.19198.48187.55--
Accumulated Other Comprehensive Income
-2.07-2.85-3.01-3.06--
Retained Earnings
-186.89-178.35-177.98-162.49-119.54-
Shareholders' Equity
29.421917.4922.0139.2635.69
Total Liabilities & Equity
34.8128.5927.6528.5645.0540.69
Total Debt
-0.120.240.350.480.65
Net Cash (Debt)
19.4414.0912.3711.7522.6720.72
Net Cash Growth
37.93%13.95%5.27%-48.18%9.43%693.39%
Net Cash Per Share
5.528.6914.8617.2836.1857.37
Book Value
29.421917.4922.0139.2635.69
Book Value Per Share
8.3511.7121.0232.3762.6598.83
Tangible Book Value
16.275.563.337.1930.3826.39
Tangible Book Value Per Share
4.623.434.0010.5748.4873.08
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q